Lymphoma Trial, Recruiting (NCT05841914)

Lymphoma Trial, Recruiting NCT05841914 Sponsor: Vinodh Kakkassery, MD Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT05841914 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People whose doctors suspect they may have a type of eye lymphoma (lymphoma affecting the inside of the eye), and for whom a surgical procedure to examine the jelly-like fluid inside the eye (called a vitrectomy) has already been recommended as part of their diagnosis.
People who are 18 years of age or older.
People who have given written consent to take part in the study.

Who may not be able to join:

People who have received chemotherapy treatment for lymphoma in the 3 months before their planned eye surgery.
People who have used cortisone (a type of steroid medication) within 2 weeks before their planned eye surgery, or who have certain eye conditions including fluid build-up at the back of the eye (macular oedema), scarring between the iris and the lens (posterior synechiae), or abnormal blood vessel growth on the iris (rubeosis iridis). (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vinodh Kakkassery, PD Dr.med., University of Luebeck

Phone: +49451-500-50868

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05841914

Sponsor: Vinodh Kakkassery, MD

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

Trial contact: +49451-500-50868

More information: https://clinicaltrials.gov/study/NCT05841914

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People whose doctors suspect they may have a type of eye lymphoma (lymphoma affecting the inside of the eye), and for whom a surgical procedure to examine the jelly-like fluid inside the eye (called a vitrectomy) has already been recommended as part of their diagnosis.
People who are 18 years of age or older.
People who have given written consent to take part in the study.

Who may not be able to join:

People who have received chemotherapy treatment for lymphoma in the 3 months before their planned eye surgery.
People who have used cortisone (a type of steroid medication) within 2 weeks before their planned eye surgery, or who have certain eye conditions including fluid build-up at the back of the eye (macular oedema), scarring between the iris and the lens (posterior synechiae), or abnormal blood vessel growth on the iris (rubeosis iridis). (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Vinodh Kakkassery, MD

Registry

ClinicalTrials.gov

Start date

1 June 2023

Est. completion

30 September 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

To implement a standardised diagnostic work-up of vitreous samples from patients with suspected VRL; Rate of correct diagnosed VRL and vitritis with the use of extended molecular diagnostics versus standard work-up alone; Rate of patients with VRL or vitritis within the follow up of 24 Months after diagnostics

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov